Global Integrin Beta 8 Market is expected to grow significantly due to their pipeline products during the forecast period

Download Sample

Published Date: July 2023

This gene codes for a single-pass type I membrane protein that belongs to the integrin beta chain family and has a VWFA domain and four cysteine-rich repeats. Integrins are the primary receptors for cell adhesion to extracellular matrix proteins in metazoans, and they also play a role in some cell-cell adhesions, transmembrane connections to the cytoskeleton, and the activation of various intracellular signaling cascades in vertebrates. Integrin beta-8 is a 95-kDa glycosylated polypeptide that looks like other beta-chain integrins. In mature synapses in mouse and rat brains, it forms a heterodimer with the Alpha-V chain.

The report " Global Integrin Beta 8 Market, By Disease (Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy), By Application (Flow cytometry, CyTOF and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

Corbus Pharmaceuticals (NSDQ:CRBP) has signed licensing agreements for two monoclonal antibodies (mAbs) it has called CRB-601 and CRB-602.The business purchased CRB-601, a high-potency anti-alpha V beta 8 (anti-avb8 mAb) antibody from the University of California, San Francisco. Both alpha V beta 6 and alpha V beta 8 are inhibited by the CRB-602 antibody. Panorama Research Inc. provided Corbus with the antibody (Sunnyvale, Calif.). The mAb, according to Corbus, has the potential to treat fibrotic disorders.

Analyst View:

Integrin beta 8 is gaining attention as a potential therapeutic target for a variety of diseases and cancers. Continuing clinical trials and studies on Integrin beta 8 as a potential cancer therapy option are expected to boost the Integrin beta 8 market over the projected period. A crucial element driving global market expansion is the increased focus on new research by government agencies and significant corporations. Due to a growth in the number of people suffering from various health problems, the global Integrin beta 8 market is increasing.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Integrin Beta 8 Market, By Disease (Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy), By Application (Flow cytometry, CyTOF and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

The Global Integrin Beta 8 Market is segmented based on the disease, application, and region.

By Disease, the Global Integrin Beta 8 Market is segmented into Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy.
By Application, the Global Integrin Beta 8 Market is segmented into Flow cytometry, CyTOF and Others.
By Region, the Global Integrin Beta 8 Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape:

Key players operating in the global Integrin beta 8 market includes Bio-Rad, LifeSpan Biosciences, OriGene, RanD system, Corbus Pharmaceuticals and Others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period